Literature DB >> 11444723

Management of paracetamol overdose: current controversies.

E Kozer1, G Koren.   

Abstract

Paracetamol (acetaminophen) is one of the most frequently used analgesics, and is the most commonly used substance in self-poisoning in the US and UK. Paracetamol toxicity is manifested primarily in the liver. Treatment with N-acetyl-cysteine (NAC), if started within 10 hours from ingestion, can prevent hepatic damage in most cases. Pharmacokinetic data relating plasma paracetamol concentration to time after ingestion have been used to generate a 'probable hepatoxicity line' to predict which cases of paracetamol overdose will result in hepatotoxicity and should be treated with NAC. However, later studies use a 25% lower line as their 'possible hepatotoxicity line'. Although adopting the original line may save considerable resources, further studies are needed to determine whether such an approach is safe. On the basis of the metabolism of paracetamol, several risk factors for paracetamol toxicity have been proposed. These risk factors include long term alcohol (ethanol) ingestion, fasting and treatment with drugs that induce the cytochrome P450 2E1 enzyme system. Although some studies have suggested that these risk factors may be associated with worse prognosis, the data are inconclusive. However, until further evidence is available, we suggest that the lower line should be used when risk factors are present. In Canada and the UK, the intravenous regimen for NAC is used almost exclusively; in the US, an oral regimen is used. Both regimens have been shown to be effective. There is no large scale study with direct comparison between these 2 therapeutic protocols and controversy still exists as to which regimen is superior. During the last few years there has been an increase in the number of reports of liver failure associated with prolonged paracetamol administration for therapeutic reasons. The true incidence of this phenomenon is not known. We suggest testing liver enzyme levels if a child has received more than 75 mg/kg/day of paracetamol for more than 24 hours during febrile illness, and to treat with NAC when transaminase levels are elevated. Paracetamol overdose during pregnancy should be treated with either oral or intravenous NAC according to the regular protocols in order to prevent maternal, and potentially fetal, toxicity. Unless severe maternal toxicity develops, paracetamol overdose does not appear to increase the risk for adverse pregnancy outcome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444723     DOI: 10.2165/00002018-200124070-00003

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.228


  87 in total

1.  Acetaminophen toxicity in an urban county hospital.

Authors:  F V Schiødt; F A Rochling; D L Casey; W M Lee
Journal:  N Engl J Med       Date:  1997-10-16       Impact factor: 91.245

2.  Changing patterns of self-poisoning in a UK health district.

Authors:  M C Bialas; P G Reid; P Beck; J H Lazarus; P M Smith; R C Scorer; P A Routledge
Journal:  QJM       Date:  1996-12

3.  Improvement of portal flow and hepatic microcirculatory tissue flow with N-acetylcysteine in dogs with obstructive jaundice produced by bile duct ligation.

Authors:  G Kigawa; H Nakano; K Kumada; N Kitamura; S Takeuchi; T Hatakeyama; M Yamaguchi; H Nagasaki; K Boudjema; D Jaeck
Journal:  Eur J Surg       Date:  2000-01

4.  Favourable neonatal outcome following maternal paracetamol overdose and severe fetal distress. Case report.

Authors:  S K Rosevear; P L Hope
Journal:  Br J Obstet Gynaecol       Date:  1989-04

Review 5.  Classification, etiology, and considerations of outcome in acute liver failure.

Authors:  R Williams
Journal:  Semin Liver Dis       Date:  1996-11       Impact factor: 6.115

6.  Effect of methylxanthines on acetaminophen hepatotoxicity in various induction states.

Authors:  T F Kalhorn; C A Lee; J T Slattery; S D Nelson
Journal:  J Pharmacol Exp Ther       Date:  1990-01       Impact factor: 4.030

7.  Phenobarbital induction and acetaminophen hepatotoxicity: resistance in the obese Zucker rodent.

Authors:  R A Blouin; P Dickson; P J McNamara; M Cibull; C McClain
Journal:  J Pharmacol Exp Ther       Date:  1987-11       Impact factor: 4.030

8.  Fasting-induced depletion of glutathione in the aging mouse.

Authors:  B L Vogt; J P Richie
Journal:  Biochem Pharmacol       Date:  1993-07-20       Impact factor: 5.858

9.  Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat.

Authors:  V F Price; M G Miller; D J Jollow
Journal:  Biochem Pharmacol       Date:  1987-02-15       Impact factor: 5.858

10.  Mechanism of fasting-induced suppression of acetaminophen glucuronidation in the rat.

Authors:  V F Price; J M Schulte; S M Spaethe; D J Jollow
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

View more
  7 in total

1.  N-Acetylcysteine, a glutathione precursor, reverts vascular dysfunction and endothelial epigenetic programming in intrauterine growth restricted guinea pigs.

Authors:  Emilio A Herrera; Francisca Cifuentes-Zúñiga; Esteban Figueroa; Cristian Villanueva; Cherie Hernández; René Alegría; Viviana Arroyo-Jousse; Estefania Peñaloza; Marcelo Farías; Ricardo Uauy; Paola Casanello; Bernardo J Krause
Journal:  J Physiol       Date:  2016-12-04       Impact factor: 5.182

2.  N-acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms.

Authors:  Chantal Bémeur; Javier Vaquero; Paul Desjardins; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2010-04-30       Impact factor: 3.584

3.  Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

Authors:  Steven D LaRowe; Pascale Mardikian; Robert Malcolm; Hugh Myrick; Peter Kalivas; Krista McFarland; Michael Saladin; Aimee McRae; Kathleen Brady
Journal:  Am J Addict       Date:  2006 Jan-Feb

4.  Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.

Authors:  Kang Yiu Lai; Wing Yiu George Ng; Fan Fanny Cheng
Journal:  Infect Dis Poverty       Date:  2014-11-28       Impact factor: 4.520

Review 5.  Effects of the Usage of l-Cysteine (l-Cys) on Human Health.

Authors:  Noelia Clemente Plaza; Manuel Reig García-Galbis; Rosa María Martínez-Espinosa
Journal:  Molecules       Date:  2018-03-03       Impact factor: 4.411

6.  Approaches toward repeated supratherapeutic doses of paracetamol in children: a survey of medical directors of poison centres in North America and Europe.

Authors:  Eran Kozer; Michael McGuigan
Journal:  Drug Saf       Date:  2002       Impact factor: 5.228

Review 7.  Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?

Authors:  Francesco Scaglione; Orlando Petrini
Journal:  Clin Med Insights Ear Nose Throat       Date:  2019-01-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.